pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Jun 6·1 min read
save

Growing Amish population poses unique public health challenges, says STAT opinion piece

Jun 6, 2026·read at STAT ↗Neutral

The First Opinion podcast explored how the expanding Amish community impacts public health, noting that the group may approach 2 million people in the United States by 2075. While some political figures have claimed the Amish do not vaccinate and have lower autism rates, the discussion highlighted that the reality is far more nuanced.

Hosts and guests examined Amish attitudes toward vaccines, health‑care costs, and broader medical issues, emphasizing that cultural beliefs shape their health decisions. The conversation also considered how health‑care providers and policymakers might address these differences without alienating the community.

The piece underscored that the growing size of the Amish population will increasingly influence public‑health planning, especially in areas such as disease prevention and resource allocation. It called for more research and culturally sensitive outreach to better understand and serve this unique group.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Opinion: How the Amish think about vaccines, health care costs, and much more”

read at STAT ↗
6,071 words · retrieved Jun 6
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Ultragenyx Pharmaceutical Inc.3ALUMIS INC.Boundless Bio, Inc.Clinic for Special ChildrenOVERSEASUNIQUE
topics
Vaccines14Vaccine8Type 2 Diabetes4Rare Disease3Hematology2Oncology2AsthmaCardiologyHypertensionNeurologyPsychiatry & CNS

related stories

  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • 7h agoGSK laying off 1.2K+ in BelgiumBioSpace
  • Dec 22Fierce Biotech Fundraising Tracker '26: OMass obtains $310M; Soufflé cooks up $135MFierce Biotech
  • Sep 17Chutes & Ladders—Legend poaches Novartis vet to boost commercial potentialFierce Biotech
  • Sep 17Purer fentanyl won’t solve the U.S. overdose death crisis, study saysSTAT